NHS National Framework Agreement for the supply of Human Cell Line Recombinant Factor VIII products
key details
| Value | £4,125,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33141000 +1 more |
| Deadline | 23 Mar 2016 |
| Contract start | 1 Jul 2016 |
| Contract end | 31 Jan 2019 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-53ede3b7-adc9-11e6-9901-0019b9f3037b |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Please refer to "Parties appointed to the framework agreement" | £3,750,000 | 1 Jun 2016 | active |
description
NHS National framework agreement for the supply of Human Cell Line Recombinant Factor VIII products. The framework will commence on 1st July 2016 to 31st March 2017, with options to extend for up to a further 39 months. Please refer to the ITO, Document No.05d for a list of Participating Authorities.
Additional information: The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England, Wales, Scotland and Northern Ireland. The framework may also be used by private sector contractors and agents working on behalf of the above. Please refer to Document 05d in the ITO documents for the list of Participating Authorities
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 18 Nov 2016 | Planning (planning) | · | f413d580-82c2-4361-b222-b2f5b5ca6f95-86613 |
| 17 Aug 2018 | Award update (awardUpdate) | · | bf1cdcad-df59-4c76-814c-eb270e2319ac-235737 |
more from COMMERCIAL MEDICINES UNIT
- NHS Framework Agreement for Branded Pharmaceuticals - North of England Tranche A. · £575,675,600 · 24 Apr 2017
- NHS Framework Agreement for the Midlands and East Pharmacy Purchasing Group for the supply of Proprietary Pharmaceuticals - Tranche B · £102,379,487 · 24 Apr 2017
- Contract for the supply of BCG vaccine · 9 Jan 2017
- Contract for the supply of human papillomavrius vaccine · 22 Dec 2016
- NHS National Pharmaceuticals - Wave 10c Offer reference number: CM/PHG/15/5466 Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 40 months. Potential periods of call-offs under the framework agreement: Oral Products: All Regions 01/07/2017 to 28/02/2019 (20 months) Hospital Only Products: Central and South West (CESW) 01/07/2017 to 30/06/2018 (12 months); North West and Eastern and North London (NWLN) 01/07/2017 to 30/06/2018 (12 months) and South East and South London and North East and Yorkshire (LSNE) 01/07/2017 to 30/06/2018 (12 months) · £182,500,000 · 16 Dec 2016
- NHS Framework Agreement for Hepatitis C Medicines for Midlands and East and North of England regions · £85,000,000 · 25 Nov 2016
- Invitation to offer for NHS Framework Agreement for Branded Pharmaceuticals for London – Tranche A (inc. Hepatitis C) · £201,544,684 · 18 Nov 2016
- Contract for the supply of BCG vaccine · 18 Nov 2016
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Laboratory Consumables · University of Portsmouth Higher Education Corporation
- Trocars · University Hospitals of Leicester NHS Trust · £922,924
- BIS Monitoring · East Sussex Healthcare NHS Trust · £193,575
- Central Venous Catheters and Associated Products · Supply Chain Coordination Limited · £136,500,000
- Provision of Crime Scene Consumables and DNA Kits · The Police and Crime Commissioner for Humberside · £215,000
- Blood Collection Devices · Supply Chain Coordination Limited · £244,000,000
- Human Derived Blood Products · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £69,978,867
- Vascular Therapy · Dorset County Hospital NHS Foundation Trust · £34,184
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.